ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Back pain"

  • Abstract Number: 0567 • ACR Convergence 2021

    Determinants of Health-Related Quality of Life in Spondyloarthritis and Comparison with Chronic Low Back Pain – Results from a Nation-Wide Study

    Helena Santos1, Ana Rita Henriques2, Ana Maria Rodrigues3, Jaime Branco3 and Helena Canhao3, 1Portuguese Institute of Rheumatology, Lisbon, Portugal, 2EpiDoC Unit, Comprehensive Health Research Centre (CHRC), Lisbon, Portugal, 3EpiDoC Unit, CEDOC, NOVA Medical School, Comprehensive Health Research Centre (CHRC), Lisbon, Portugal

    Background/Purpose: Spondyloarthritis (SpA) causes pain, fatigue, stiffness, loss of physical function and impaired health-related quality of life (HRQoL).This study aims to: 1) to compare HRQoL…
  • Abstract Number: 0919 • ACR Convergence 2021

    Ixekizumab Shows a Distinct Pattern of Pain Improvement Beyond Measurable Inflammation as Assessed by MRI or CRP or BASDAI Questions 5 & 6 in Patients with Ankylosing Spondylitis

    Kurt de Vlam1, Philip Conaghan2, Philip Mease3, Proton Rahman4, Venkatesh Krishnan5, Rebecca Bolce5, David Sandoval Calderon5, So Young Park5, Gaia Gallo5 and Walter Maksymowych6, 1University Hospitals Leuven, Leuven, Belgium, 2Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 3Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, WA, 4Department of Medicine, Eastern Health and Memorial University of Newfoundland, St John's, NL, Canada, 5Eli Lilly and Company, Indianapolis, IN, 6Department of Medicine, Division of Rheumatology at the University of Alberta, Alberta, Canada

    Background/Purpose: Ixekizumab (IXE) demonstrated rapid efficacy in patients (pts) with AS at week (W) 16 in the absence of elevated inflammation as measured by baseline…
  • Abstract Number: 1024 • ACR Convergence 2021

    Medical Care Seeking Is Frequent and Associated with Overuse of Low-Value Care for Low Back Pain in Portugal: Results from a Nationwide Population-Based Study

    Luís Antunes Gomes1, Eduardo Brazete Cruz2, Ana Rita Henriques1, Jaime Branco3, Helena Canhão4 and Ana Maria Rodrigues3, 1EpiDoC Unit, Comprehensive Health Research Centre (CHRC), Lisbon, Portugal, 2Comprehensive Health Research Centre (CHRC), Setubal, Portugal, 3EpiDoC Unit, CEDOC, Nova Medical School, Comprehensive Health Research Centre (CHRC), Lisbon, Portugal, 4EpiDoC Unit, Comprehensive Health Research Centre (CHRC), Lisboa, Portugal

    Background/Purpose: Low back pain (LBP) constitutes an important cause of disability and morbidity in general population. Appropriate care for LBP includes non-pharmacological interventions based on…
  • Abstract Number: 1116 • ACR Convergence 2021

    Disease Characteristics of Steroid-Induced Spinal Epidural Lipomatosis: A Systematic Review

    Haseeb Chaudhary1, Usama Nasir2, Khezar Syed3, Abigayle Sullivan3, Shilla Zachariah3, Christian AkemDimala3, Muhammad Khan4 and Anthony Donato3, 1Tower Health System, Reading, PA, 2Reading Hospital, Tower Health System, Reading, PA, 3Reading Hospital, Tower Health System, Reading, PA, 4University of Kentucky, Lexington, KY

    Background/Purpose: Steroid-induced epidural lipomatosis (SEL) is a rare phenomenon causing neuronal compression from adipose tissue deposition in the epidural space. We analyzed the available literature…
  • Abstract Number: 1306 • ACR Convergence 2021

    Clinical and Imaging Characteristics of Spondyloarthritis Among Crohn’s Disease Patients

    Laarni Quimson1, Nisa Oren2, Catherine Burns3 and Reem Jan2, 1University of Chicago, Oak Park, IL, 2University of Chicago, Chicago, IL, 3Indiana University, Indianapolis, IN

    Background/Purpose: Inflammatory bowel disease (IBD) affects up to 1.3% of the population and is associated with musculoskeletal manifestations including spondyloarthritis (SpA). Axial SpA (axSpA) is…
  • Abstract Number: 1314 • ACR Convergence 2021

    Predictive Factors for the Development Acute Anterior Uveitis Attacks in Patients with Axial Spondyloarthritis; The Results of a Longitudinal Analysis

    Haluk Cinaklı1, Elif Ediboglu1, Eda Otman Akat2, Dilek Solmaz3, Gulay Alp1, Esra Erpek1, Sercan Gücenmez4, Mustafa Ozmen4 and Servet Akar3, 1Izmir Katip Celebi University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, İzmir, Turkey, 2katip çelebi, izmir, Turkey, 3Izmir Katip Celebi University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey, 4katip çelebi university, izmir, Turkey

    Background/Purpose: Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic disease mainly affecting sacroiliac joints and spine. Peripheral arthritis, dactylitis and enthesitis may also occur. Acute…
  • Abstract Number: 1587 • ACR Convergence 2021

    Do Physical Therapists Use Recommended Treatments for Chronic Low Back Pain?

    Debbie Feldman1, Jonathan El-Khoury2, Tatiana Orozco1, François Desmeules3, Maude Laliberté1 and Kadija Perreault4, 1Université de Montréal, Montréal, QC, Canada, 2Université de Sherbrooke, Sherbrooke, QC, Canada, 3Research Centre of Hôpital Maisonneuve Rosemont, Montréal, QC, Canada, 4Université Laval, Québec City, QC, Canada

    Background/Purpose: Chronic low back pain has been the subject of many studies in medicine and physical therapy for over half a century. Clinical practice guidelines…
  • Abstract Number: 1919 • ACR Convergence 2021

    Detection of Radiographic Sacroiliitis with an Artificial Neural Network in Patients with Suspicion of Axial Spondyloarthritis

    Denis Poddubnyy1, Fabian Proft2, Kay-Geert Hermann2, Laura Spiller2, Stefan Niehues2, Lisa Adams2, Mikhail Protopopov2, Valeria Rios Rodriguez2, Burkhard Muche2, Judith Rademacher2, Murat Torgutalp2, Keno Bressem2 and Janis Vahldiek2, 1Department of Rheumatology, Charité – Universitätsmedizin, Berlin, Germany, 2Charité University Medicine Berlin, Berlin, Germany

    Background/Purpose: Conventional radiography of the sacroiliac joints is still recommended as the first imaging method for the diagnosis of axial spondyloarthritis (axial SpA). In many…
  • Abstract Number: 1876 • ACR Convergence 2020

    The Role of HLA B27 in Axial Spondyloarthritis: Prevalence and Performance as a Marker in an Argentinian Cohort

    Rodrigo Garcia Salinas1, Santiago Ruta1, Einer Sanchez Prado1, Jessica Torres Chichande1, Alvaro Ruta1, Facundo Salvatori1 and Sebastian Magri1, 1Hospital Italiano La Plata, La Plata, Argentina

    Background/Purpose: HLA B27 prevalence in Latin America are heterogeneous and timeless, we propose to estimate the prevalence of HLA B27 in an Argentinian cohort of…
  • Abstract Number: 0317 • ACR Convergence 2020

    Axial Involvement in Psoriatic Arthritis in a Comprehensive Rapid Diagnosis Program (Reuma-check PsA). Analysis of Its Characteristics

    Rodrigo Garcia Salinas1, Santiago Ruta2, Jessica Torres Chichande1, Einer Sanchez Prado1, Facundo Salvatori1 and Sebastian Magri1, 1Hospital Italiano La Plata, La Plata, Argentina, 2Hospital Italiano La Plata, Buenos Aires, Argentina

    Background/Purpose: To date, there is no consensus that allows an appropriate definition of axial involvement in PsA, that ranges between 25 to 70%. To estimate…
  • Abstract Number: 1894 • ACR Convergence 2020

    Use of Facebook and Electronic Patient Portal to Identify Axial Spondyloarthritis in Patients with Chronic Back Pain

    Yuliya Afinogenova1, Swetha Alexander2, Andrew Haims3 and Abhijeet Danve4, 1Yale University, Orange, CT, 2University of Connecticut, New Haven, 3Yale University, New Haven, CT, 4Yale University, Rocky Hill, CT

    Background/Purpose: Delay in diagnosis of Axial Spondyloarthritis (axSpA) remains a significant unmet need and can be partially attributed to lack of timely rheumatology referral. Current…
  • Abstract Number: 0344 • ACR Convergence 2020

    Use of the BASDAI in Psoriatic Arthritis Patients with and Without Axial Disease

    Soumya Reddy1, M. Elaine Husni2, Jose Scher3, Ethan Craig4, Alexis Ogdie4 and Jessica Walsh5, 1NYU School of Medicine, New York, NY, 2Cleveland Clinic, Cleveland, OH, 3NYU School of Medicine, New York City, 4University of Pennsylvania, Philadelphia, PA, 5University of Utah School of Medicine, George E. Wahlen Veteran Affairs Medical Center, Salt Lake City, UT

    Background/Purpose: The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) is increasingly being used to assess the activity of axial disease in patients with psoriatic arthritis…
  • Abstract Number: 0505 • ACR Convergence 2020

    Secukinumab Provides Sustained Improvements in Clinical and Imaging Outcomes in Patients with Psoriatic Arthritis and Axial Manifestations: Results from the MAXIMISE Trial

    Xenofon Baraliakos1, Laure Gossec2, Effie Pournara3, Slawomir Jeka4, Ricardo Blanco5, Salvatore D'Angelo6, Georg Schett7, Barbara Schulz3, Michael Rissler3, Dermot Whyms8, Chiara Perella3 and Laura Coates9, 1Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Bochum, Germany, 2Sorbonne Université and Hôpital Universitaire Pitié Salpêtrière, Paris, France, 3Novartis Pharma AG, Basel, Switzerland, 42nd Univ Hospital, CM UMK, Bydgoszcz, Poland, 5Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain, 6Rheumatology Department of Lucania and Rheumatology Institute of Lucania (IRel), San Carlo Hospital of Potenza, Potenza, Italy, 7Friedrich-Alexander-Universität Erlangen- Nuremberg, Erlangen, Germany, 8Novartis Ireland Limited, Dublin, Ireland, 9University of Oxford, Oxford, United Kingdom

    Background/Purpose: Axial disease may affect up to 25–70% of psoriatic arthritis (PsA) patients, depending on the definition used. Current evidence on efficacy of biologics in…
  • Abstract Number: 0681 • ACR Convergence 2020

    Gout and Serum Urate Levels Are Associated with Lumbar Spine Monosodium Urate Deposition and Chronic Low Back Pain: A Dual-Energy CT Study

    Michael Toprover1, Michael Mechlin2, Anastasia Slobodnick3, Virginia Pike4, Cheongeun Oh5, Claudine Davis2, Theodore Fields6, Fabio Becce7 and Michael Pillinger8, 1New York University Langone Health, New York, NY, 2NYU Langone Health, New York, NY, 3Stamford Health Medical Group, Stamford, CT, 4NYU Langone Health, Brooklyn, NY, 5NYU Grossman School of Medicine, New York, 6Hospital for Special Surgery, New York, NY, 7Lausanne University, Lausanne, Switzerland, 8New York University Grossman School of Medicine, New York,, NY

    Background/Purpose: Spinal gout is reported as a rare event, presenting as acute back pain, neuropathy, and spinal compression. Diagnosis is commonly based on identification of…
  • Abstract Number: 0695 • ACR Convergence 2020

    Chronic Inflammatory Back Pain Occurring Later in Life: A Neglected Concept

    Lauren Ridley1, Nahid Rianon2, Mark Hwang3, MinJae Lee4, Lianne Gensler5, Michael Ward6, Matthew Brown7, Amirali Tahanan2, Mohammad Rahbar2, Mariko Ishimori8, Michael Weisman9 and John Reveille10, 1McGovern Medical School at UTHealth, Houston, TX, 2McGovern Medical School at UTHealth, Houston, 3McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, 4UT Southwestern, Dallas, 5University of California San Francisco, San Francisco, CA, 6National Institutes of Health, Bethesda, MD, 7Guy's and St Thomas, NHS Foundation Trust and King's College London NIHR Biomedical Research Centre, King's College London, London, United Kingdom, London, United Kingdom, 8Cedars-Sinai Medical Center, Los Angeles, CA, 9Distinguished Professor of Medicine Emeritus, David Geffen School of Medicine at UCLA, LOS ANGELES, CA, 10Department of Internal Medicine, University of Texas, Houston, TX

    Background/Purpose: Chronic back pain (CBP) is a common musculoskeletal complaint and a significant cause of disability (Weisman et al., 2013). A subset of CBP, chronic…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology